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Summary
An interleukin 3-dependent multipotential stem cell clone, LyD9, has been shown to generate
mature B lymphocytes, macrophages, and neutrophils by coculture with primary bone marrow
stromal cells. We report here that coculture with the cloned stromal cell lines PA6 and ST2
can support differentiation of LyD9 cells predominantly into granulocyte/macrophage colony-
stimulating factor (GM-CSF)- and granulocyte (G)-CSF-responsive cells, respectively . However,
these stromal cell lines were unable to support lymphopoiesis ofLyD9 cells. The GM-CSF-dependent
line, L-GM, which was derived fromLyD9 cells cocultured withPA6 stromal cells, could differentiate
into macrophages and granulocytes in the presence of GM-CSF. The LGM line can further
differentiate predominantly into neutrophils by coculture with ST2 stromal cells. The G-CSF-
dependent line, LG, which was derived from LyD9 cells cocultured with ST2 stromal cells,
differentiated into neutrophils in response to G-CSF. Although the stromal cell-supported
differentiation ofLyD9 cells required the direct contact between LyD9 and stromal cells, a small
fraction ofLyD9 cells that were pretreated with 5-azacytidine could differentiate into neutrophils
and macrophages without direct contact with stromal cells. These results indicate that different
stromal cell lines support lineage-selective differentiation of theLyD9 stem cell and that 5-azacytidine
treatment can bypass the requirement of direct contact with stromal cells, albeit with a lower
frequency.
T
he totipotent bone marrow stem cell is defined as a cell
that has the potential to reproduce itself as well as to
give rise to cells of each lineage in the blood . During the
course of differentiation, progeny of the totipotent stem cell
gradually lose their` capacity to differentiate into particular
lineages, giving rise to multipotent stem cells that eventually
become committed to a single cell lineage. Stem cells
proliferate, differentiate, and mature in the presence ofgrowth
factors . The totipotent bone marrow stem cell has been difficult
to maintain in vitro because a growth factor for the totipo-
tent stem cell has not been isolated . On the other hand, mo-
lecular cloning ofcDNAs encoding growth factors and lym-
phokines, and their large-scale production, have facilitated
establishment of multipotent stem cell lines and progenitor
cell lines cultured in vitro (1-3) . IL3 has been shown to sup-
port the growth of multipotent stem cells without induc-
tion of differentiation (4, 5) . Several progenitor cell lines such
as FDCP-mix A4 and 32D C13 can be induced to a specific
lineage by a lineage-specific growth factor, although they
generally proliferate and remain undifferentiated in media con-
taining IL-3 (6, 7) .
Another regulatory element ofhematopoiesis is a stromal
cell network in the bone marrow. This idea is supported by
the finding that bone marrow stromal cells are a necessary
requirement for a long-term bone marrow culture system,
in which hemopoiesis ofvarious cell lineages can be sustained
without added growth factors (8, 9) . Interestingly, the
hemopoietic cells must be in direct contact with the stromal
cells for proliferation and differentiation (10) . Recently, stromal
cell lines such as PA6 and ST2 (11-13) were shown to sup-
port differentiation of primary bone marrow cells into dis-
tinct lineage cells (14) . Such functional diversity of stromal
cells could be ascribed to different growth factors produced
or differential cell adhesion molecules expressed by each stromal
cell . Combination of appropriate growth factors derived from
stromal cells and growth factor receptors expressed by pro-
genitor cells might be a key element for the lineage-specific
differentiation . In addition, an appropriate pair of cell adhe-
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required for not only proliferation signal triggering but also
specific growth factor/receptor expression .
The above experiments using primary bone marrow cells
do not allow to distinguish (a) that a stromal cell line selec-
tively expanded progenitors that were alreadycommittedand
(b) that the stromal cell line supported differentiation of a
multipotential stem cell in either stochastic or directivemanner.
It is therefore interesting to know whether different lineage
cells differentiate from a single stem cell by coculture with
different stromal cell lines. To address this question, we took
advantage of an IL-3-dependent stem cell clone, LyD9 . This
clone has been shown to differentiate into multiple lineage
cells by coculture with bone marrow stromal cells: B lym-
phocytes, neutrophils, and macrophages (15-18) . Differenti-
ation of LyD9 cells requires direct contact with primary
stromal cells (16) . We have found that two stromal cell lines,
PA6 (11) and ST2 (13), are able to support differentiation of
theLyD9 stem cell line predominantlyinto two different lin-
eage cells: granulocyte/macrophage-colony-stimulating factor
(GM-CSF)t-responsive and granulocyte CSF (G-CSF)-re-
sponsive cells, respectively.
Materials and Methods
Cell Lines .
￿
The procedure for the establishment and detailed
characterization of the LyD9 cell clone has been described (15) .
It grows in RYMI 1640 supplemented with 10% (vol/vol) FCS,
50 fAM 2-ME, 2MM r.-glutamine, and5% WEHI 313-conditioned
medium . The LyD9 cell line was recloned in our laboratory. The
ST2-S10 (ST2) and MC3T3-G2/PA6 (PA6) cell lines were estab-
lished from thebone marrow ofNZBmice and the preadipose tissue
of calvaria of newborn mice, respectively (11, 13) .
SAzacytidine TreatmentofLyD9 Cells.
￿
5-Azacytidine treatment
of LyD9 cells before coculture was carried out basically according
to Castellazzi et al . (19) . 5-Azazrytidine was added to 5 jAg/ml in
a 5-ml culture ofLyD9 cells (106 cells/ml). The concentration of
5-azacytidinewas diluted to halfby the addition of an equalvolume
offreshmedium after 24hofthe culture. 2d later, cells were washed
to remove 5-azacytidine, cultured for 10 d, andused for induction .
Induction of Differentiation with Stromal Cell Lines.
￿
LyD9 cells
(106) or 5-azacytidine-treated LyD9 cells (106) were cocultured on
either ST2 or PA6 cells . To test the requirement of direct contact,
cells were separatedfrom stromal layers by a membrane chamber
(pore size, 0.45Am) (Millipore Continental Water Systems, Bed-
ford, MA) . Thecondition for coculture is thesame as that for main-
tenance ofLyD9 cells, except that WEHI 313-conditionedmedium
is reduced to 0.7% for theminimal maintenance oftheLyD9 cells.
After a 1-d coculture, floating cells were removed, and adhering
cells were further cultured for the inductionof differentiation . PA6
and ST2 stromal cell layers were changed several times during the
coculture, and the culture supernatant (0.7%) ofWEHI 313 cells
was supplied in coculture every third day. Every week thereafter,
the cocultured LyD9 cells were harvested and washed, and then
106 cells were transferred to wells containing oneofthe following
CSFs : GM-CSF (20 U/ml), macrophage CSF (M-CSF) (10% of
I Abbreviation used in thispaper: GM-CSF, granulocyte/macrophage colony-
stimulating factor.
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theL cell culture supernatant), andG-CSF (100 U/ml) . Viable cells
were counted 10 d after the transfer to growth factor-containing
medium.
Establishment oftheLGMLine.
￿
LyD9 cells were maintained on
a monolayer ofPA6stromal cells in the presence of 0.7% ofWEHI
313 culture supernatant. 4 wk later, cocultured LyD9 cells were
transferred to media containing GM-CSF (20 U/ml) . GM-CSF-
responding cells were maintained for>2 mo, and their morphology,
cytochemical staining, surface phenotypes, and responsiveness to
the growth factors were characterized . TheLGM line was main-
tained in media containing IL-3 .
Establishment oftheLG Line.
￿
LyD9 cells pretreated with 5-azacy-
tidine werecocultured on ST2 stromal cells as described above, and
transferred after 4 wk to media containing G-CSF (100 U/ml) .
G-CSF-responding cells obtained were transferred to the medium
containing alow concentration of 11,3 afterweconfirmed that cells
became nonviable without G-CSF. Morphological andcytochem-
ical analyses ofLG cells were performed after culturing in G-CSF
for 10 d.
Antibodies andFlow Cytometry .
￿
The surface phenotypeofLGM
cells was determined by immunofluorescence staining with anti-
bodies as follows: FITC-labeled polyclonal goat anti-mouse IgM
(Cappel Laboratories, Malvern, PA) ; FITC-labeled monoclonal anti-
la (Meiji Institute of Health Science, Kanagawa, Japan) ; and 6132
(anti-13220) (20), 2AG2 (anti-Fcy receptor) (21),M1/70 (anti-MacI)
(22), and F4/80 (23) were detected by biotin-conjugated goat
anti-rat IgG and FITC-avidin . FRCS® (Becton Dickinson & Co.,
Mountain View, CA) was used for the analysis . Rabbit anti-GM-
CSFantibody was provided by Toray Industries, Inc. (Tokyo, Japan) .
One unit of the antibody neutralizes 10 U of GM-CSF.
Characterization ofLyD9 Cellsand their Derivatives.
￿
May-Griin-
wald-Giemsa staining was used for morphological study . Staining
of a-naphthylbutyrate and naphthol AS-D chloroacetate esterase
was done by acommercial kit(Muto Chemical Company, Tokyo,
Japan) . To determine the phagocytic activity,LGM cells were stimu-
latedwith 100ng/mlPM (Sigma Chemical, Co ., St . Louis,MO)
for3 h . Cells werewashed with the culturemedium, and incubated
with latex beads (0.8 p,m; Sigma Chemical Co.) for 6 h . After
removal of themedium, cells were washed several times with the
medium without FCS, stained with May-Grunwald-Giemsa, and
observed by a phase contrast microscope (x 1000) .
GrowthAssay ofLGMandLG.
￿
Proliferative responses ofLGM
andLG cells to each growth factor were determined as described
previously (17) . LGM andLG cells (4 x 10 4 cells/200 pl) were
incubated in microtiter wells in the culture medium containing
the growth factors indicated . The cultures in duplicate were in-
cubated at 37°C . Cell proliferation was measured by [3H]thymi-
dine uptake during the last 6 h of the 48 h incubation.
Growth Factors.
￿
Purified human rIL2 was provided by Takeda
Pharmaceutical Company (Osaka, Japan) . 11,3 was obtained from
culture supernatant ofWEHI 313 cells. IL4 and 11,5 were obtained
from X63Ag8 myeloma cells transferred with 11Aand 11,5 cDNA,
respectively (24-26). Purified human rIL6 (27) was provided by
Dr. T . Hirano (Osaka University) . Murine rGM-CSF (28) was
provided by Dr. T Sutlo (Biomaterials Research Institute Co.,
Kanagawa, Japan) . PurifiedhumanrG-CSF (29) andhuman M-CSF
were provided by Dr . S. Nagata (Osaka Bioscience Institute) . PA6
cells (106) were layered on a plate in the same medium as that for
LyD9 cells, except for the absence of IL3 . LPS (1 Fig/ml; Sigma
Chemical Co.) was added during last 3 d of the culture. The cul-
ture supernatant ofPA6 cells was collected on day 5, and concen-
trated by a nitrocellulose membrane filter (0.45pm;YM10;Amicon
Corp., Danvers, MA) .Results
Generation of Myeloid Cells from LyD9 Cells by Coculture
with Stromal CellLines . Differentiation ofLyD9 cells by cocul-
ture with the stromal cell line PA6 was investigated by mor-
phological and cytochemical studies. A considerable propor-
tion (ti0.1%) of LyD9 cells cocultured with PA6 cells for
4 wk contained myeloid-like nuclei and became positive for
myeloid-specific enzymes such as a-naphthylbutyrate esterase
and myeloperoxidase (Fig . 1) . The proportion ofmyeloid cells
increased whenLyD9 cells were pretreated with 5-azacytidine .
Similar experiments using ST2 stromal cells did not yield
a detectable number of myeloid cells . However, 5-azacytidine-
treatedLyD9 cells cocultured withST2 cells produced a con-
siderable portion (N0.1%) of myeloid cells (data not shown) .
To characterize differentiated cells, an aliquot (106 cells)
of LyD9 cells cocultured with the stromal cell line (either
PA6 or ST2) was transferred everyweek to media containing
eitherGM-CSF, G-CSF, or M-CSF. Viable cells were scored
10 d after the transfer to growth factor-containing media .
As shown in Table 1, 4-wk coculture ofLyD9 cells with PA6
cells generated a significant number ofGM-CSF-responding
cells and a smallnumber of G-CSF-responding cells . Pretreat-
ment ofLyD9 cells with 5-azacytidine enhanced and acceler-
ated the induction of LyD9 cells into the myeloid cells by
PA6 stromal cells. By contrast, whenPA6 cells were replaced
by ST2 cells, no GM-CSF-responding cells were generated,
whereas a smallnumber ofG-CSF-responding cells were pro-
duced (Table 1) . 5-Azarytidine-treated LyD9 cells differen-
tiated into G-CSF-responding cells more quickly and more
efficiently by coculture with ST2 cells . Similar experiments
with PA6 or ST2 cells did not give rise to M-CSF-responsive
cells even after 4 wk of coculture.
Establishment ofGM-CSF- and G-CSF-dependent Cell Lines
from LyD9 Cells. LyD9 cells that had been cocultured with
PA6 stromal cells were cultured in media containing GM-
CSF for >4 wk, and thereafter, grown cells were maintained
as a cell line called DGM . Similarly, the IrG line was gener-
ated from 5-azacytidine-treatedLyD9 cells by coculture with
the ST2 stromal line, followed by subsequent selection in
G-CSF-containing medium . IrGM and IrG cells grew in the
presence ofGM-CSF and G-CSF, respectively (Fig. 2) . How-
ever, the growth response of IrG cells to G-CSF was tran-
Figure 1 .
￿
Morphological and cytochemical analyses of original LyD9 and cocultured LyD9 cells. Original LyD9 (a-c) and cocultured LyD9 (d-f )
cells were analyzed morphologically by May-Grunwald-Giemsa staining (a and d), and cytochemically with cx-naphthylbutyrate esterase (brown) and
naphthol (AS-D) chloroacetate esterase (blue) (b and e), and myeloperoxidase (c andf) . Pictures of LyD9 cells cocultured with PA6 cells for 4 wk
are presented representatively . Arrowheads indicate typical myeloid cells (x200) .
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Figure 2 .
￿
Growth stimulation ofLGM and IrG cells by growth factors.
[3H]Thymidine incorporation intoLGM (a) and ILG (b) cells was mea-
sured inthepresence ofgrowth factors indicated . Concentrations ofgrowth
factors indicated on the horizontal line as 1 were as follows: IL2, 10 U/ml
human rIIr2 ; IL3, 20% of WEHI-3B culture supernatant ; 114 and IL5,
20% of culture supernatant of X63Ag8 myeloma cells transfected with
IIL4 and 11,5 cDNAs, respectively; IL6, 100 U/ml human rIL6 ; GM-
CSF, 50 U/ml rGM-CSF; M-CSF, 100 ng/ml rM-CSF ; and G-CSF, 100
U/ml rG-CSF. These concentrations ofgrowth factors give maximal growth
response to each positive control cell . LGM and IrG cells cultured without
growth factors (indicated on the horizontal line as 0) incorporated 668
and 488 cpm, respectively. The data represent the mean ofduplicate cultures.
sient . IrGM and DG cells proliferated in response to IIT3,
thus, they were maintained in IL3-containing media . No other
growth factors examined could induce proliferation ofITGM
and LG cells.
Cytochemical studies were performed to characterize the
differentiation properties of theITGM and ITG lines cultured
in GM-CSF and G-CSF, respectively (Fig . 3). About one-
third of the DGM cells that had been cultured in the pres-
ence of GM-CSF had bent nuclei with a small nucleal-
cytoplasmic ratio (Fig . 3 a) . LGM cells also were positive
for ci-naphthylbutyrate esterase and myeloperoxidase (Fig. 3,
b and c) . Only a few neutrophils (<0.01%) were found in
ITGM cells . LGM cells showed phagocytic activity when
stimulated withPMA (Fig . 3 d ) . A few percent of theDGM
cells appeared as mature macrophages even when cultured
in IIT3 for 1 mo. By contrast, the majority of ITG cells that
had been cultured for 10 d in the presence ofG-CSF became
neutrophils with typical lobulated nuclei and naphthol AS-D
chloroacetate esterase-positive granules (Fig. 3, e and f) .
The surface phenotype ofITGM cells was consistent with
that of myeloid lineage cells . As shown in Fig. 4,LGM cells
expressed more Mac 1, F4/80, and la antigens than LyD9
cells . Expression of the B220 and Fc-y receptor antigens on
ITGM was as high as that on LyD9 cells.LGM cells did not
express IgM . Surface antigens of the ITG line could not be
studied because of the strong auto-fluorescence of this line.
LGM Cells Can Differentiate into Neutrophils.
￿
WhenITGM
cells were further cocultured with ST2 cells in the presence
of 25 Ag/ml LPS for 1 mo, -30% of the cocultured ITGM
cells had the morphological and cytochemical properties of
neutrophils (Fig . 5) . Similar experiments with another GM-
CSF-dependent derivative of LyD9,K-GM (17), yielded similar
results (data not shown) . Since monocyte/macrophage lin-
eage cells appeared inLGM and K-GM cells that had been
cultured with GM-CSF, these results indicate that bothITGM
Table 1 .
￿
Generation ofGM-CSF and G-CSF-responding Cells by Coculture ofLyD9 Cells with Stromal Cell Lines
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LyD9 cells with or without 5-azacytidine pretreatment were cocultured with either ST2 or PA6 stromal cell line for the weeks indicated, and 106
LyD9 cells were transferred to the medium containing GM-CSF (20 U/ml) or G-CSF (100 U/ml) . 10 d after the transfer, viable cells were counted .
Same sets of the experiment with M-CSF or without growth factor addition did not give rise to any survived cells (data not shown) . Aliquots taken
at 1-wk coculture did not yield any viable cells .
Pretreatment
of LyD9 cells
Period of
coculture
PA6
+ GM-CSF + G-CSF +GM-CSF
ST2
+ G-CSF
wk
None 2 0 0 0 0
3 <100 <100 0 <100
4 6x10 5 700 0 500
5-Azacytidine 2 10 3 300 0 200
3 4x10 6 4x103 0 8x103
4 5x10' 6 x 104 500 2.5 x 105Figure 3 .
￿
Morphological and cytochemical analyses of differentiated IrGM and IrG cell lines . May-Grunwald-Giemsa staining ofLGM (a) and IrG
(e) cell lines are shown . LGM (b) and IrG cell lines 0 were analyzed cytochemically with both ci-naphthylbutyrate esterase (brown) and naphthol
AS-D chloroacetate esterase (blue) . Expression of myeloperoxidase (c) and functional phagocytosis (d) oflatexbeads in theLGM cell line were examined.
Morphology of the I.G cell line maintained with IIr3 (5% ofWEHI 3B-conditioned medium) for 1 mo is shown in g . The 11,3-cultured IrG cells
were transferred to the medium containing G-CSF (100 U/ml), cultured for 10 d, and the morphology was examined (h) .
L
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Figure 4.
￿
Surface phenotype of LGM cells . Expression of surface antigens on LGM cells was examined by immunofluorescence staining, and flow
cytometrywith mAbs was indicated (see Materials and Methods) . Staining profiles of noninducedLyD9 cells were also included (
￿
) . Negative controls
were LGM cells stained with the second-step reagent only (- - -) . Data of LGM cells were also shown (
￿
).andK-GM cell lines are progenitors ofneutrophils and mac-
rophages.
G-CSF Induces Diferentiation and Eventual Death ofLG
Cells. LG cells proliferated and differentiated into neutro-
phils in the presence of G-CSF, but gradually ceased to
proliferate and the majority of them died within 2 wk . IrG
cells grew almost indefinitely when cultured in medium con-
taining 11,3 . However, the morphological characteristics of
neutrophils disappeared in the IL3 containing medium in 1
mo (Fig . 3 g) . Neutrophil characteristics such as lobular nuclei
were regained by transferring L-G cells into G-CSF-containing
medium (Fig . 3 h) . The recovery ofLG cells is not due to
the reversal of maturation but rather to the growth of the
remaining immature ILG cells, because careful limiting dilu-
tion experiments indicate that mature granulocyte clones de-
rived from LG cells by G-CSF only rarely proliferated in re-
sponse to IL-3. It is likely that not all the LG cells mature
within 2 wk in the G-CSF-containing media, and surviving
immature LG cells proliferated again in the presence of IL-3 .
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Figure 5.
￿
Differentiation of ILGM
cells into granulocytes.IrGM cells were
cocultured with ST2 cells in the pres-
ence of 25 pg/ml LPS . After 1 mo of
the coculture, the morphology of in-
duced1rGM cells was analyzed by May-
Grunwald-Giemsa staining (a), and their
expression of a-naphtylbutyrate and
naphthol AS-D chloroacetate esterase
were examined cytochemically (b)
(x 400) .
Direct Contact with Stromal Cells Is Requiredfor Myelopoiesis
from LyD9 Cells. We then tested whether direct contact of
LyD9 cells to the stromal cell lines is required for myelopoi-
esis, as previously described for lymphopoiesis from LyD9
cells by coculture with primary bone marrow stromal cells
(16) . We cultured LyD9 cells with the stromal cell lines (PA6
or ST2) intwo chambers separated by a nitrocellulose mem-
brane (0.45 lm) . Each week during this coculture, an ali-
quot ofLyD9 cells (106 cells) was transferred to media con-
taining either GM-CSF or G-CSF, and cell numbers were
determined 10 d later. As shown in Table 2, no GM-CSF-
responding cells and very few, if any, G-CSF-responding cells
appeared even after 4 wk of the coculture ofLyD9 cells with
the stromal cell lines without direct contact . These results
clearly indicate that direct contact with stromal cells is re-
quired for differentiation of LyD9 cells into myeloid cells .
SAzacytidine-treated LyD9 CellsCan Differentiate withoutDi-
rect Contact with Stromal Cells. In contrast, PA6 cells could
induce 5-azacytidine-treated LyD9 cells to differentiate into
Table 2 .
￿
Generation ofGM-CSF and G-CSF-responding Cells by the Culture ofLyD9 Cells and Stromal Cell Lines in Separate
Membrane Chambers
Experiments were done as described in Table 1, except that LyD9 and stromal cells were cultured in separate membrane chambers (pore size, 0.45 pro) .
Pretreatment
of LyD9 cells
Period of
coculture
PA6
+GM-CSF +G-CSF
ST2
+GM-CSF +G-CSF
wk
None 2 0 0 0 0
3 0 <100 0 <100
4 0 <100 0 <100
5-Azacytidine 2 <100 200 0 <100
3 105 300 0 200
4 106 1 .5 x 103 <100 2.5 x 10 3GM-CSF-responding cells without direct contact (Table 2) .
Much smaller but significant numbers ofG-CSF-responding
cells were also induced . Under the same conditions, ST2
stromal cells could support differentiation ofG-CSF-respond-
ing cells but not of GM-CSF-responding cells. The 5-azacy-
tidine treatment ofLyD9 cells before the coculture allowed
generation ofGM-CSF- and G-CSF-responding cells without
direct contact with stromal cells, but the lineage specificity
of the stromal cells was not altered by this treatment .
We then tested whether the culture supernatant of PA6
cells is able to induce differentiation ofLyD9 cells into my-
eloid cells . As shown in Table 3, 5-azarytidine-treated LyD9
cells were induced to differentiate into GM-CSF-dependent
cellsby preincubation with supernatant from PA6 cells . After
screening withknown growth factors,we found that GM-CSF
itself could replace the supernatant of PA6 cells. Anti-GM-
CSF antibody could inhibit proliferation of GM-CSF-res-
ponding cells from 5-azarytidine-treated LyD9 cells by the
PA6 supernatant . GM-CSF mRNA was found in PA6 and
ST2 cells by PCR (data not shown) .
Table 3.
￿
GM-CSF Can Induce GM-CSF-responsive Cells from
Azacytidine-treated LyD9 Cells
Growth factors
PA6 supernatant
50%
Incubation with :
Anti-GM-CSF GM-CSF-responding
antibody
￿
cells
U/ml
0
￿
6.8 x 105
5-Azacytidine-treated LyD9 cells were preincubated with various amounts
ofgrowth factors with or without anti-GM-CSF antibody . The culture
supernatant of PA6was concentrated to 10% of its original volume, and
added to the culture as indicated by final concentrations of the original .
WEHI 3B-conditioned medium was added to 0.7% to all the cultures
to maintain the viability of LyD9 cells . After 1 wk of preincubation,
2 x 106 5-azacytidine-treated LyD9 cells were transferred to the medi-
um containing 20 U/ml GM-CSF . Total viable cells were counted after
a 10-d culture in the presence of GM-CSF . LyD9 cells without
5-azacytidine pretreatment gave rise to neither GM-CSF- nor GCSF-
responding cells at the same condition as above .
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We estimated the frequency of GM-CSF-responding cells in
5-azarytidine-treated LyD9 cells by culturing these cells in
methylcellulose . As shown in Table 4, only two to six cells
out of 106 5-azarytidine-treated LyD9 cells formed colonies
in the presence ofGM-CSF, whereas 55-80% of the LyD9
cells formed colonies in the presence ofGM-CSF, whereas
55-80% of the LyD9 cells formed large colonies in the pres-
ence of11,3 . It is, therefore, likely that the 5-azarytidine treat-
ment of LyD9 cells produced a small fraction of cells that
could bypass at least a part ofthe function ofPA6 stromal cells.
Discussion
We have established a well-defined in vitro system for my-
eloid differentiation from a multipotent stem cell clone . This
system includes the stem cell clone LyD9 and the cloned
stromal cell lines PA6 and ST2 . LyD9 cells cocultured with
the PA6 and ST2 stromal cell lines differentiated predomi-
nantly into GM-CSF- and GCSF-responsive cells, respectively.
The GM-CSF-responsive (IrGM) and GCSF-responsive (DG)
lines were obtained by coculture ofLyD9 cells with PA6 and
ST2 stromal cells, respectively . 1,GM cells differentiated into
macrophages and less frequently into neutrophils in response
to GM-CSF, while LG cells differentiated into neutrophils
in response to G-CSR The IrGM line further differentiated
into neutrophils by coculture with theST2 stromal cell line.
Although 5-azarytidine-treatment ofLyD9 cells stimulated
the differentiation frequency into myeloid cells, the lineage
specificity determined by the stromal cell lines did not change .
Coculture ofLyD9 cells with the PA6 and ST2 stromal lines
did not generate eitherB lymphocytes or M-CSF-responsive
Table 4 .
￿
Frequency of GM-CSF-responding Cells in
s
6
￿
4
2
￿
1
4
￿
4
IL-3 (30 U/ml)
￿
5.5 x 105 ￿5 .5 x 10 5
8.1 x 105 ￿8 .1 x 105
5-Azacytidine-treated LyD9 cells (106) were cultured in 2.2% methyl-
cellulose containing RPMI 1640-20% FCS media (1 ml) with growth
factors indicted at 37°C under 7.5% COZ . 7 d after incubation, the
number of cell colonies (330 cells) was counted under a phase-contrast
microscope. Colonies containing >200 cells were scored as large colonies .
100%
GM-CSF
5 U/ml
0 7.0 x 105
0 3.7 x 105
S-Azacytidine-treated LyD9 Cells
No. of colonies/106 LyD9 cells
10 U/ml 0 7.2 x 105 Growth factors Total Large coloni
PA6 supernatant
50% 0.4 0 None 0 0
100% 0.4 0 0 0
GM-CSF 0 0
5 U/ml 4 0 0 0
10 U/ml 4 0 GM-CSF (30 U/ml) 2 0
None 0 0cells, even when various growth factors such as IL4, 11,5,
IL7, andM-CSF were added . Takeda et al . (18) reported that
LyD9 cells can be induced to B lymphocytes by coculture
with theRPO.10 stromal cell line. These results indicate that
different stromal cell lines allow the selective growth of par-
ticular hematopoietic lineages from a stem cell line, although
we cannot determine whether commitment was made in a
stochastic or directive manner.
The lineage specificity determined by the stromal lines may
depend on cell adhesion molecules and growth factors pro-
duced by the strornal cells . Since both PA6 and ST2 cells are
able to produce GM-CSF andM-CSF (our unpublished data),
other growth factors may be involved in determination of
different lineage specificity by thePA6 andST2 stromal cells .
ST2 stromal cells can generate G-CSF-responsive cells from
LrGM as well as LyD9 cells . ST2 stromal cells may generate
G-CSF-responsive cells from LyD9 cells theoretically via GM-
CSF-responsive cells. However, the efficiency of generation
of G-CSF-responsive cells from the IrGM line by ST2 cells
was not high enough to explain the absence of GM-CSF-
responsive cells in ST2-cocultured LyD9 cells. Thus, the
pathway involved in generating GCSF-responsive cells by ST2
cells does not seem to overlap with that generatingGM-CSF-
responsive cells by PA6 cells . Another type of stromal cells
should be responsible for generation of M-CSF-responsive
cells like LS-1 cells (17) .
In our previous system, using a primary culture of bone
marrow stromal cells, direct contact with stromal cells was
required for the proliferation and differentiation ofLyD9 cells
(16) . This conclusion was supported in the present system
using stromal cell lines because the membrane chamber ex-
periments practically abolished the generation of GM-CSF-
and G-CSF-responding cells (Table 2) . However, the present
study has shown that the cell contact requirement is circum-
vented by 5-azacytidine treatment ofLyD9 cells, though the
numbers of GM-CSF-responding cells decreased considerably
without the contact (Tables 2 and 3) . 5-Azacytidine treat-
ment is known to activate several important genes involved
in differentiation (30, 31) . Since 5-azacytidine treatment of
LyD9 cells allowed generation of GM-CSF-responding cells,
it is likely that stromal cell contact induces transcription of
a set of genes that are activated by 5-azacytidine treatment .
As the 5-azacytidine-treatedLyD9 cells gave rise to GM-CSF-
responsive cells, genes activated by this treatment may in-
clude those for (a) the GM-CSF receptor, (b) the cytoplasmic
signal transduction pathway of the GM-CSF receptor, and
(c) the regulatory proteins for target genes activated byGM-
CSF. In fact GM-CSF receptor expression is required at least
because theGM-CSF receptor was not expressed on theLyD9
cells by thebinding assay (32) . Comparison of these two cells,
i .e., LyD9 cells and GM-CSF-responsive derivatives, will pro-
vide important clues to understanding which genes need to
be activated for the lineage commitment .
We previously reported the establishment of several different
myeloid progenitor cells derived from theLyD9 cell (17) . The
K-5 cell line proliferates without differentiation in the pres-
ence of either IL5 or IL3 (33) . K-5 cells differentiate into
neutrophils and macrophages by coculture with PA6 stromal
cells . K-GM andIrGM cells proliferate in the presence of ei-
ther 11,3 or GM-CSF. Both cells can be induced to differen-
tiate into neutrophils when cocultured withST2 stromal cells.
LS-1 cells grow in the presence of any of the four growth
factors : IL3, GM-CSF, G-CSF, and M-CSF (17) . IrG cells
grow in the presence of IL3 and differentiate in response to
G-CSF. These derivatives can be classified into two groups :
(a) those that differentiate by coculture with stromal cells
(K-5, K-GM, and IrGM), and (b) those (LS-1 and ILG) that
can be induced to differentiate by growth factors .
Transfer of several IIr3-dependent cell lines from IL3 to
a different CSF results in the induction of terminal differen-
tiation. FDCP-mix (4, 7), NFS-60 (34), and 32D C13 (6)
cell lines respond to GM-CSF, erythropoietin, and G-CSF,
respectively. All these lines are distinct fromLyD9 but rather
similar to its committed derivatives like LS-1, DGM, K-GM,
and IrG cells because the above three lines are committed
to either myeloid or erythroid lineages, whereas LyD9 cells
are not committed to either the myeloid or the lymphoid
lineage (17) . Coculture of LyD9 cells with PA6 and ST2
stromal cells will thus provide a useful system to dissect mo-
lecular mechanisms ofcommitment to the myeloid lineage.
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